Influenza B Virus antibody

Catalog No. ABIN316658

The Mouse Monoclonal anti-Influenza B Virus antibody is suitable to detect Influenza B Virus in samples from Influenza B Virus. It has been validated for IF and IHC (fro).

Quick Overview for Influenza B Virus antibody (ABIN316658)

Target: Influenza B Virus

Reactivity: Influenza B Virus

Host: Mouse

Clonality: Monoclonal

Conjugate: Un-conjugated

Application: Immunofluorescence (IF), Immunohistochemistry (Frozen Sections) (IHC (fro))

Clone: 1131

Product Details

Characteristics: Synonyms: Influenza B Nucleoprotein NP

Purification: Purified IgG prepared by affinity chromatography on Protein A

Immunogen: Influenza B virus preparation

Isotype: IgG2b

Application Details

Application Notes: Immunohistochemistry on frozen sections. Immunofluorescence.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Restrictions: For Research Use only

Handling

Concentration: 1.0 mg/mL

Buffer: PBS containing 0.09 % Sodium Azide (NaN3) as preservative

Preservative: Sodium azide

Precaution of Use: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C/-20 °C

Storage Comment: Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer. Avoid repeated freezing and thawing.
Shelf life: one year from despatch. Caution: (A full Health and Safety assessment is available upon request) This product containsSodium Azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled bytrained staff only.

Expiry Date: 12 months

Target Details

Target: Influenza B Virus

Target Type: Virus

Background: Influenza virus type B is a genus in the virus family Orthomyxoviridae, responsible for acute respiratory illnesses in humans. It varies antigenically from influenza virus types A and C and is not divided into any subtypes. The gradual evolution of Influenza virus type B occurs via a series of mutations known as antigenic drift, in the surface glycoprotein haemagglutinin (HA), enabling the virus to evade the immune system and potentially re-infect the same host. HA glycoproteins from the Influenza virus type B are included in the annually updated trivalent flu vaccine, along with the Influenza virus type A subtypes H3N2 and H1N1.Synonyms: Influenza B Virus